Selected presentations describing Cyclocreatine Phosphate and the novel Nourin molecular biomarkers from peer-reviewed submissions to the American Heart Association (AHA), the American Association of Immunologists (AAI), Society for Cardiovascular Angiography and Interventions (SCAI), as well as an invited presentation on the anti-inflammatory drug, Cyclosporin H entitled: Cyclosporin H: A Novel Anti-Inflammatory Therapy with Applications for Covid-19 Patients.
Cyclocreatine Protects Against Ischemic Injury and Enhances Cardiac Recovery During Early Reperfusion
Cyclocreatine Phosphate: A Novel Mechanism for Preventing Development of Heart Failure
Nourin-Associated miRNAs: Novel Inflammatory Monitoring Markers for Cyclocreatine Phosphate Therapy in Heart Failure
Nourin-dependent miR-137: A Novel Early Diagnostic Biomarker for Unstable Angina Patients
Nourin-dependent miR-106b: A Novel Early Inflammatory Diagnostic Biomarker for Cardiac Injury
Cyclosporin H: A Novel Anti-Inflammatory Therapy with Applications for Covid-19 Patients
Nourexin-4: A Novel Anti-inflammatory Therapy for Influenza Flu